These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors. Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634 [TBL] [Abstract][Full Text] [Related]
3. Gene therapy of ovarian cancer with IFN-alpha-producing fibroblasts: comparison of constitutive and inducible vectors. Indraccolo S; Moserle L; Tisato V; Gola E; Minuzzo S; Roni V; Persano L; Chieco-Bianchi L; Amadori A Gene Ther; 2006 Jun; 13(12):953-65. PubMed ID: 16511522 [TBL] [Abstract][Full Text] [Related]
4. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity. Odaka M; Sterman DH; Wiewrodt R; Zhang Y; Kiefer M; Amin KM; Gao GP; Wilson JM; Barsoum J; Kaiser LR; Albelda SM Cancer Res; 2001 Aug; 61(16):6201-12. PubMed ID: 11507073 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer. Kong B; Wang W; Liu C; Song L; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Wang B; Wei MQ; Yang Q In Vivo; 2003; 17(2):153-6. PubMed ID: 12792977 [TBL] [Abstract][Full Text] [Related]
6. Antineoplastic activity of lentiviral vectors expressing interferon-alpha in a preclinical model of primary effusion lymphoma. Calabrò ML; Gasperini P; Di Gangi IM; Indraccolo S; Barbierato M; Amadori A; Chieco-Bianchi L Blood; 2009 May; 113(19):4525-33. PubMed ID: 19196659 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin. Shiau AL; Teo ML; Chen SY; Wang CR; Hsieh JL; Chang MY; Chang CJ; Chao J; Chao L; Wu CL; Lee CH BMC Cancer; 2010 May; 10():245. PubMed ID: 20509975 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells. Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495 [TBL] [Abstract][Full Text] [Related]
9. The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. Moserle L; Indraccolo S; Ghisi M; Frasson C; Fortunato E; Canevari S; Miotti S; Tosello V; Zamarchi R; Corradin A; Minuzzo S; Rossi E; Basso G; Amadori A Cancer Res; 2008 Jul; 68(14):5658-68. PubMed ID: 18632618 [TBL] [Abstract][Full Text] [Related]
10. Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation. Hara H; Kobayashi A; Narumi K; Kondoh A; Yoshida K; Nishimoto T; Ohashi M; Higashihara E; Ohnami S; Yoshida T; Aoki K Cancer Immunol Immunother; 2009 Jul; 58(7):1007-21. PubMed ID: 18998126 [TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice. Hase R; Miyamoto M; Uehara H; Kadoya M; Ebihara Y; Murakami Y; Takahashi R; Mega S; Li L; Shichinohe T; Kawarada Y; Kondo S Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8737-44. PubMed ID: 16361561 [TBL] [Abstract][Full Text] [Related]
12. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma. Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558 [TBL] [Abstract][Full Text] [Related]
13. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells. Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955 [TBL] [Abstract][Full Text] [Related]
14. An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels. Zahedi P; Stewart J; De Souza R; Piquette-Miller M; Allen C J Control Release; 2012 Mar; 158(3):379-85. PubMed ID: 22154933 [TBL] [Abstract][Full Text] [Related]
15. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels. Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394 [TBL] [Abstract][Full Text] [Related]
16. IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile. Horton HM; Dorigo O; Hernandez P; Anderson D; Berek JS; Parker SE J Immunol; 1999 Dec; 163(12):6378-85. PubMed ID: 10586027 [TBL] [Abstract][Full Text] [Related]
17. Adenoviral-mediated interferon alpha overcomes resistance to the interferon protein in various cancer types and has marked bystander effects. Zhang X; Yang Z; Dong L; Papageorgiou A; McConkey DJ; Benedict WF Cancer Gene Ther; 2007 Mar; 14(3):241-50. PubMed ID: 17096027 [TBL] [Abstract][Full Text] [Related]
18. Adenovirus and retrovirus mediated interferon alpha gene transfer into CD34+ cells maintains regeneration capacity and enhances adhesion molecules in K562 cells. Seiter K; Kancherla R; Yang L; Quan S; Farley TJ; Abraham NG; Ahmed T J Investig Med; 1999 Sep; 47(8):414-24. PubMed ID: 10510594 [TBL] [Abstract][Full Text] [Related]
19. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels. Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947 [TBL] [Abstract][Full Text] [Related]
20. [Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo]. Jiang WY; Kang JL; Wang XX; Yang WJ; Nie ML; Zhou C Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):778-83. PubMed ID: 24406137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]